Prescient advances cancer drug to unlock value
Prescient Therapeutics is entering a critical stage with clinical progress, regulatory tailwinds and commercial opportunity converging.
Prescient Therapeutics is entering a critical stage with clinical progress, regulatory tailwinds and commercial opportunity converging.
Nova Minerals has strengthened ties with key Alaskan lawmakers and other stakeholders during a board visit to its 9.9Moz Estelle gold and critical minerals project.
As listed players like Vita Life Sciences and EZZ chase wellness demand, Complementary Medicines Group is stepping up with a clinically backed supplement targeting one of Australia’s most common pain points.
Octava Minerals has an option to acquire the Federation copper-silver-zinc project in Tasmania where historical drilling returned significant intersections.
BHP production strong though weak iron ore price hurts the margins, yet it’s upbeat about copper prices and its $3.2bn foray into Argentina.
America is doubling down on anti-dumping duties for Chinese graphite, after accusing the country of exporting the mineral at unfairly low prices.
GTI Energy has secured approval to start drilling its Lo Herma uranium project in Wyoming as the US looks to rebuild its domestic supply chain.
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
Morgans’ Scott Power says while innovation is important, a path to profitability is key to a successful emerging ASX healthcare company.
Green Technology Metals’ maiden rubidium resource adds a new dimension to the strategic value of its Seymour project in Ontario, Canada.
The ASX wobbled as Tesla stalled and Bapcor crashed, while Fortescue surged and Northern Star ditched its gold hedge.
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
Original URL: https://www.couriermail.com.au/business/stockhead/page/6